EUVIMEDEUVIMED entdecken
Crossref

A Newly Synthesized Benzimidazolium Salt: 1‐(2‐Cyanobenzyl)‐3‐(4‐Vinylbenzyl)‐1 H ‐Benzo[ D ]imidazol‐3‐ium Chloride as a Potential Anticancer Agent for Colon Cancer Treatment, In Vitro Study

Nazmiye Bitgen, Mustafa Cakir, Senem Akkoc, Hamiyet Donmez-Altuntas

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Nazmiye Bitgen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri, Türkiye. Hauptthemen laut MEDLINE: Colonic Neoplasms, Antineoplastic Agents, Benzimidazoles, Apoptosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: We acknowledge the financial support for this study from the Erciyes University Scientific Research Projects (BAP) unit (TSA-2021-10877) and the Betul Ziya Ere….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colon cancer is one of the most common cancer‐related deaths. Drug resistance is one of the biggest challenges in cancer treatment. Numerous pharmacological and biochemical investigations have documented the benzimidazole ring's anticancer, anti‐inflammatory, and antioxidant properties. Within the scope of our project, the effect of newly synthesized benzimidazolium salt (BS) on cell proliferation was tested with MTT assay, and its effect on apoptosis and cell cycle was tested with annexin V and PI in the two different colon cancer cell lines (HT‐29 and DLD‐1). Our study examined the expressions of some genes related to apoptosis and, additionally, caspase activities with the multicaspase kit. BS showed an antiproliferative effect at lower doses in HT‐29 colon cancer cells. When HT‐29 cells were exposed to a 20 µM dosage, they showed increased caspase activity and apoptosis compared to DLD‐1 cells. HT‐29 accumulated in the G2/M phase of the cell cycle, whereas DLD‐1 cells accumulated more in the S phase. In HT‐29 cells, colony formation was inhibited; however, in DLD‐1 cells, this effect was insufficient. Based on the apoptosis‐death pathway, BS is expected to have anti‐cancer effects. As a result of this work, this chemical was thoroughly examined in two different colon cancer cell lines, and additional, more comprehensive initiatives are being planned in light of the information obtained from this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsAntineoplastic AgentsBenzimidazolesApoptosisHumansHT29 CellsCell ProliferationCell Cycle

Stichwörter der Autor:innen

apoptosisbenzimidazolium saltcolon cancer

Substanzen

Antineoplastic AgentsBenzimidazoles

Autor:innen und Institutionen

  • Department of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.
  • Genome and Stem Cell Center, Erciyes University, Kayseri, Türkiye.
  • Department of Medical Biology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Türkiye.
  • Department of Basic Pharmaceutical Sciences, Faculty of Pharmacy, Suleyman Demirel University, Isparta, Türkiye.
  • Faculty of Engineering and Natural Sciences, Bahçeşehir University, Istanbul, Türkiye.

Förderung

  • We acknowledge the financial support for this study from the Erciyes University Scientific Research Projects (BAP) unit (TSA-2021-10877) and the Betul Ziya Ere…

Zitieren

APA

Bitgen, N., Cakir, M., Akkoc, S., & Donmez-Altuntas, H. (2025). A Newly Synthesized Benzimidazolium Salt: 1‐(2‐Cyanobenzyl)‐3‐(4‐Vinylbenzyl)‐1 H ‐Benzo[ D ]imidazol‐3‐ium Chloride as a Potential Anticancer Agent for Colon Cancer Treatment, In Vitro Study. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70112

Vancouver

Bitgen N, Cakir M, Akkoc S, Donmez-Altuntas H. A Newly Synthesized Benzimidazolium Salt: 1‐(2‐Cyanobenzyl)‐3‐(4‐Vinylbenzyl)‐1 H ‐Benzo[ D ]imidazol‐3‐ium Chloride as a Potential Anticancer Agent for Colon Cancer Treatment, In Vitro Study. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70112

BibTeX
@article{Bitgen2025,
  author = {Bitgen, Nazmiye and Cakir, Mustafa and Akkoc, Senem and Donmez-Altuntas, Hamiyet},
  title = {A Newly Synthesized Benzimidazolium Salt: 1‐(2‐Cyanobenzyl)‐3‐(4‐Vinylbenzyl)‐1 H ‐Benzo[ D ]imidazol‐3‐ium Chloride as a Potential Anticancer Agent for Colon Cancer Treatment, In Vitro Study},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70112}
}
Kostenlos starten →